Repeated administration of d-amphetamine results in a time-dependent and dose-independent sustained increase in urinary excretion of p-hydroxyamphetamine in mice

Journal of Health Science

Volumn 53, Issue 4, 2007, Pages 371-377

  Carvalho, Félix ^a   Soares, Maria Elisa ^a   Fernandes, Eduarda ^a   Remião, Fernando ^a   Carvalho, Márcia ^a   Duarte, José Alberto ^a   Pires das Neves, Ricardo ^b   Pereira, Maria De Lourdes ^b   Bastos, Maria De Lourdes ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF AVEIRO   (Portugal)

Author keywords

d amphetamine; Humans; Metabolism; Mice; p hydroxyamphetamine

Indexed keywords

CYTOCHROME P450; DEXAMPHETAMINE; HYDROXYAMPHETAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAGE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DEPENDENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY CORTEX; KIDNEY TUBULE; MOUSE; MOUSE STRAIN; NONHUMAN; QUANTITATIVE ANALYSIS; TIME; URINALYSIS; URINARY EXCRETION;

MUS;

EID: 34547566233     PISSN: 13449702     EISSN: 13475207     Source Type: Journal    
DOI: 10.1248/jhs.53.371     Document Type: Article

References (26)

1. Caldwell, J. (1980) The metabolism of amphetamines and related stimulants in animals and man. In Amphetamines and related stimulants: Chemical biological and sociological aspects (Caldwell, J. Ed.), CRC Press, Boca Raton, pp.29-46.
2. Yamada, H., Oguri, K. and Yoshimura, H. (1986) Effects of several factors on urinary excretion of methamphetamine and its metabolites in rats. Xenobiotica, 16, 137-141.
3. Bach, M. V., Coutts, R. T. and Baker, G. B. (1999) Involvement of CYP2D6 in the in vitro metabolism of amphetamine, two N-alkylamphetamines and their 4-methoxylated derivatives. Xenobiotica, 29, 719-732.
4. Law, M. Y., Slawson, M. H. and Moody, D. E. (2000) Selective involvement of cytochrome P450 2D subfamily in in vivo 4-hydroxylation of amphetamine in rat. Drug Metab. Dispos., 28, 348-353.
5. Carvalho, F., Remião, F., Amado, F., Domingues, P., Correia, A. J. and Bastos, M. L. (1996) d-amphetamine interaction with glutathione in freshly isolated rat hepatocytes. Chem. Res. Toxicol., 9, 1031-1036.
6. Jones, A. L. and Simpson, K. J. (1999) Review article: mechanisms and management of hepatotoxicity in ecstasy (MDMA) and amphetamine intoxications. Aliment. Pharmacol. Ther., 13, 129-133.
7. Foley, R. J., Kapatkin, K., Verani, R. and Weinman, E. J. (1984) Amphetamine-induced acute renal failure. South. Med. J., 77, 258-260.
8. Cartledge, J. J., Chow, W. M. and Stewart, P. (1998) Acute renal failure after amphetamine presenting with loin pain. Br. J. Urol., 81, 160-161.
9. Diehl, K. H., Hull, R., Morton, D., Pfister, R., Rabemampianina, Y., Smith, D., Vidal, J. M. and van de Vorstenbosch, C. (2001) A good practice guide to the administration of substances and removal of blood, including routes and volumes. J. Appl. Toxicol., 21, 15-23.
10. Soares, M. E., Carvalho, F. and Bastos, M. L. (2001) Determination of amphetamine and its metabolite p-hydroxyamphetamine in rat urine by reversed-phase high-performance liquid chromatography after dabsyl derivatization. Biomed. Chromatogr., 15, 452-456.
11. Karch, S. B. (1993) Synthetic stimulants. In The pathology of drug abuse (Karch, S. B, Ed.), CRC Press, Boca Raton, pp.165-218.
12. Carvalho, F., Remiao, F., Soares, M. E., Catarino, R., Queiroz, G. and Bastos, M. L. (1997) damphetamine-induced hepatotoxicity: possible contribution of catecholamines and hyperthermia to the effect studied in isolated rat hepatocytes. Arch. Toxicol., 71, 429-436.
13. Carvalho, F., Fernandes, E., Remiao, F. and Bastos, M. L. (1999) Effect of d-amphetamine repeated administration on rat antioxidant defences. Arch. Toxicol., 73, 83-89.
14. Carvalho, F., Duarte, J. A., Neuparth, M. J., Carmo, H., Fernandes, E., Remiao, F. and Bastos, M. L. (2001) Hydrogen peroxide production in mouse tissues after acute d-amphetamine administration. Influence of monoamine oxidase inhibition. Arch. Toxicol., 75, 465-469.
15. Carvalho, F., Fernandes, E., Remiao, F., Gomes-Da-Silva, J., Tavares, M. A. and Bastos, M. L. (2001) Adaptative response of antioxidant enzymes in different areas of rat brain after repeated damphetamine administration. Addict. Biol., 6, 213-221.
16. Carvalho, M., Carvalho, F., Remiao, F., Pereira, M. L., Pires-das-Neves, R. and Bastos, M. L. (2002) Effect of 3,4-methylenedioxymethamphetamine ("ecstasy") on body temperature and liver antioxidant status in mice: influence of ambient temperature. Arch. Toxicol., 76, 166-172.
17. de Groot, M. J., Bijloo, G. J., Martens, B. J., van Acker, F. A. A. and Vermeulen, N. P. E. (1997) A refined substrate model for human cytochrome P450 2D6. Chem. Res. Toxicol., 10, 41-48.
18. van der Weide, J. and Steijns, L. S. (1999) Cytochrome P450 enzyme system: genetic polymorphisms and impact on clinical pharmacology. Ann. Clin. Biochem., 36, 722-729.
19. Bertz, R. J. and Granneman, G. R. (1997) Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions. Clin. Pharmacokinet., 32, 210-258.
20. Law, M. Y. and Moody, D. E. (2000) Urinary excretion of 4-hydroxyamphetamine and amphetamine in male and female Sprague-Dawley and Dark Agouti rats following multiple doses of amphetamine. Toxicol. Lett., 117, 139-144.
21. Terada, Y., Shinohara, S., Matui, N. and Ida, T. (1988) Amphetamine-induced myoglobinuric acute renal failure. Jpn. J. Med., 27, 305-308.
22. Ginsberg, M. D., Hertzman, M. and Schmidt-Nowara, W. W. (1970) Amphetamine intoxication with coagulopathy, hyperthermia, and reversible renal failure. A syndrome resembling heatstroke. Ann. Intern. Med., 73, 81-85.
23. Scandling, J. and Spital, A. (1982) Amphetamine-associated myoglobinuric renal failure. South. Med. J., 75, 237-240.
24. McCann, U. D., Wong, D. F., Yokoi, F., Villemagne, V., Dannals, R. F. and Ricaurte, G. A. (1998) Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428. J. Neurosci., 18, 8417-8422.
25. Hoffman, W. F., Moore, M., Templin, R., McFarland, B., Hitzemann, R. J. and Mitchell, S. H. (2006) Neuropsychological function and delay discounting in methamphetamine-dependent individuals. Psychopharmacology (Berl), 188, 162-170.
26. Jansen, K. L. (1999) Ecstasy (MDMA) dependence. Drug Alcohol Depend., 53, 121-124.